Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


Articles published in Eur J Cancer

Retrieve available abstracts of 12 articles:
HTML format
Text format



Single Articles


    April 2018
  1. ANDREASSEN BK, Grimsrud TK, Haug ES
    Bladder cancer survival: Women better off in the long run.
    Eur J Cancer. 2018;95:52-58.
    PubMed     Text format     Abstract available


    February 2017
  2. KAWADA T
    Bladder cancer and smoking with special reference to education.
    Eur J Cancer. 2017;75:1-2.
    PubMed     Text format    


    October 2016
  3. VAN DER HEIJDEN AG, Mengual L
    Reply to letter commenting on: A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32449.
    PubMed     Text format    


  4. ORSOLA A, Mullane SA, Bellmunt J
    Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernandez PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer
    Eur J Cancer. 2016 Oct 30. pii: S0959-8049(16)32448.
    PubMed     Text format    


  5. GOOSSENS ME, Zeegers MP, van Poppel H, Joniau S, et al
    Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
    Eur J Cancer. 2016;69:9-18.
    PubMed     Text format     Abstract available


  6. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, et al
    Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Eur J Cancer. 2016;69:1-8.
    PubMed     Text format     Abstract available


    July 2016
  7. VAN DER HEIJDEN AG, Mengual L, Lozano JJ, Ingelmo-Torres M, et al
    A five-gene expression signature to predict progression in T1G3 bladder cancer.
    Eur J Cancer. 2016;64:127-136.
    PubMed     Text format     Abstract available


    April 2016
  8. WESTHOFF E, Maria de Oliveira-Neumayer J, Aben KK, Vrieling A, et al
    Low awareness of risk factors among bladder cancer survivors: New evidence and a literature overview.
    Eur J Cancer. 2016;60:136-145.
    PubMed     Text format     Abstract available


    January 2016
  9. RIBAL MJ, Mengual L, Lozano JJ, Ingelmo-Torres M, et al
    Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
    Eur J Cancer. 2016;54:131-138.
    PubMed     Text format     Abstract available


    December 2015
  10. POUESSEL D, Chevret S, Rolland F, Gravis G, et al
    Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
    Eur J Cancer. 2015;54:69-74.
    PubMed     Text format     Abstract available


  11. HERMANS TJ, Fransen van de Putte EE, Horenblas S, Lemmens V, et al
    Perioperative treatment and radical cystectomy for bladder cancer - a population based trend analysis of 10,338 patients in the Netherlands.
    Eur J Cancer. 2015;54:18-26.
    PubMed     Text format     Abstract available


    September 2015
  12. GO H, Kim PJ, Jeon YK, Cho YM, et al
    Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Eur J Cancer. 2015;51:1937-45.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: